Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Sleep Apnea Syndromes: HELP
Articles by Aristeidis H. Katsanos
Based on 1 article published since 2010
(Why 1 article?)
||||

Between 2010 and 2020, Aristeidis H. Katsanos wrote the following article about Sleep Apnea Syndromes.
 
+ Citations + Abstracts
1 Review Noninvasive Ventilatory Correction in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. 2017

Tsivgoulis, Georgios / Alexandrov, Andrei V / Katsanos, Aristeidis H / Barlinn, Kristian / Mikulik, Robert / Lambadiari, Vaia / Bonakis, Anastasios / Alexandrov, Anne W. ·From the Department of Neurology, University of Tennessee Health Science Center, Memphis (G.T., A.V.A., A.W.A.) · Second Department of Neurology (G.T., A.H.K., A.B.) and Second Department of Internal Medicine (V.L.),"Attikon" University Hospital, National and Kapodistrian University of Athens, Greece · Department of Neurology, University of Ioannina, Greece (A.H.K.) · Department of Neurology, Carl Gustav Carus Hospital Dresden, Germany (K.B.) · and International Clinical Research Center, Neurology Department, St Anne's Hospital and Masaryk University, Brno, Czech Republic (R.M.). ·Stroke · Pubmed #28596449.

ABSTRACT: BACKGROUND AND PURPOSE: Even though current guidelines suggest that noninvasive ventilatory correction (NIVC) could be considered for acute ischemic stroke patients with obstructive sleep apnea, available evidence is conflicting, with no adequately powered randomized clinical trial being available to date. METHODS: We conducted a systematic review and meta-analysis of all available literature data evaluating the effect of NIVC on neurological improvement (based on decrease in National Institutes of Health Stroke Scale score), vascular events (recurrent stroke, transient ischemic attack, myocardial infarction and unstable angina), and mortality during the follow-up period. RESULTS: We identified 4 randomized clinical trials and 1 prospectively matched observational cohort, comprising a total of 389 patients (59.8% males, mean age: 64.4 years). The risk of both performance and detection bias was considered high in most of the included randomized clinical trials because of the lack of blinding in participants, personnel and/or outcome assessors. The mean decrease in National Institutes of Health Stroke Scale scores during the first (≤30) days of acute ischemic stroke was found to be greater in NIVC-treated patients in comparison to controls (standardized mean difference, 0.38; 95% confidence interval, 0.11-0.66; CONCLUSIONS: NIVC seems to be associated with greater short-term neurological improvement in acute ischemic stroke patients with obstructive sleep apnea. This finding deserves further investigation within the settings of an adequately powered, sham-control, randomized clinical trial.